Indeed, Ate-Grab treatment relieved chemotherapy-induced desmoplasia in a PDAC model by sequestering PlGF/VEGF within the TME and thus inhibiting CAF activation, especially the CD141+ population, a key subset activated by gemcitabine treatment responsible for tumor fibrosis95. Here, VEGFA is linked to neoplasm.